The trademark application STEMCELL was filed by STEMCELL Technologies Canada Inc., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on September 5, 2021, and it was registered by office on December 14, 2021 without any oppositions.
The application was filed in Danish (English was selected as the second language).
The Refusal with reference B 018178582 was partially rejected according to Article 7(3) EUTMR with decision issued on May 18, 2021 by the EUIPO.
Goods And Services
The mark was filed in class 42 with Consultation, research and development services in the field of hematology, immunology, therapeutic research, and life science and contract assays services and proficiency testing services in the field of hematology, immunology, therapeutic research, and life science..
The mark was filed in class 44 with Medical services, such as, medical diagnostic services, disease therapy services and transplant services.